ImmunoPrecise
Presence
ImmunoPrecise is a company listed under the stock ticker IPA (CA).
Executives
View the org chart displaying its 11 main executives
Most searched biographies at ImmunoPrecise
- Jennifer Bath, Chief Executive Officer and President
- Dirk Witters, Director
- Mitch Levine, Chairman of the Board
Popular executive movements at ImmunoPrecise
- Mitch Levine has joined the company as Chairman of the Board (posted on November 28 2023).
- Dirk Witters has joined the company as Director (posted on September 6 2023).
- Barry Springer has joined the company as Director (posted on September 6 2023).
Create your alert
to follow the executive moves at ImmunoPrecise.
Biotechnology
ImmunoPrecise has 2,282 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
- Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
- Histogen has filed for bankruptcy protection (posted on April 19 2024).
Popular contacts in Biotechnology
News
Press releases by ImmunoPrecise
- IPA Acquires the Carterra LSA® Instrument to Enhance Antibody Discovery and Bolster Its AI Developments
- InterSystems and IPA’s Subsidiary BioStrand Collaborate to Unveil the Innovative Integration of Vector Search with LENSai for AI-Driven Healthcare Applications
- IPA Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2024*
- IPA Responds to 13D Filing
- ImmunoPrecise Antibodies Invites Investors and Stakeholders to Exclusive Interview with Market Radius Research
- ImmunoPrecise Reports Financial Results and Recent Business Highlights for Full Fiscal Year 2023
- IPA to Report Financial Results and Recent Business Highlights for Fourth Quarter and Fiscal Year End 2023 on July 7th, 2023.
- IPA’s Subsidiary BioStrand Unveils Use Case for Solving the Information Integration Dilemma (IID)
- IPA Releases New HYFT-Powered In Silico Humanization Platform, Aims to Disrupt the Transgenic Animal Model Market
- IPA's Subsidiary, BioStrand, Solves the Information Integration Dilemma (IID) for Systems Biology
- View more press releases Close
Social media about ImmunoPrecise
- ImmunoPrecise on Wikipedia, Google News & Yahoo Finance
- ImmunoPrecise on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Jennifer Bath 
Call ImmunoPrecise at +1 250...
